Modified Viral Capsids Rational Design Reproducibility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for designing viral capsids are limited by serial infectivity, chimeras generated during production, and the randomness of the process, leading to low reproducibility and limited insights into the functional properties of the capsids.
Innovation Solution
A systematic approach is applied to select candidate polypeptides with desired properties, encode their fragments, and insert them into viral vectors, allowing for tailored screening to identify fragments that confer specific properties to the viral particles, such as increased tropism and infectivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If directed evolution with serial infectivity is used to generate viral capsids, then functional capsids can be obtained through multiple generations of screening, but the process is random, unreproducible, and generates chimeras requiring multiple screening generations
Solution Approach 1:
The patent applies preliminary action by pre-defining the capsid modification strategy based on rational design principles before initiating the screening process. The capsid modifications are planned in advance according to known structural and functional constraints, eliminating the need for random mutagenesis and multiple screening generations. This approach ensures reproducibility while reducing the complexity of the overall process.
Solution Approach 2:
The patent changes the fundamental parameter of capsid design from random mutation to systematic modification based on rational design. By altering the approach from directed evolution to rational design with predefined modification rules, the process becomes reproducible and eliminates the need for multiple screening generations, directly addressing the reliability and complexity issues.
2Reliability
If rational design with systematic changes is applied to viral capsids, then functional stringency is improved, but diversity and functional potential are restricted
Solution Approach 1:
The patent applies segmentation by dividing the capsid into modular domains and regions that can be independently modified. This allows systematic changes to be applied to specific segments while maintaining the overall capsid structure and functionality. The modular approach enables functional stringency through targeted modifications while preserving diversity through combinatorial possibilities of segment arrangement and variation.
Solution Approach 2:
The patent applies local quality by making specific, targeted modifications to particular regions of the capsid based on their known functional roles. Instead of uniform systematic changes, the approach applies different modifications to different local regions according to their specific requirements, thereby maintaining functional stringency in critical areas while allowing diversity in less critical regions.
3Adaptability or versatility
If random mutagenesis is used to generate capsid variants, then diversity of sequences is achieved, but the fraction of valid in frame amino-acid substitutions is very small
Solution Approach 1:
The patent changes the parameter of sequence generation from random mutagenesis to systematic modification based on rational design. By altering the fundamental approach to capsid engineering, the process achieves both diversity and high productivity of valid substitutions, eliminating the need to rely on random chance for generating functional variants.
Data Source
AI summary
Provided are methods for identifying polypeptides that when displayed on a capsid confer a desired property to viral particles including such capsids, as well as methods for designing and manufacturing viral vectors and viral particles with improved properties.


